Friday, May 23, 2025
CN
  • About
  • Advertise
  • Careers
  • Contact
Money Compass
  • Home
  • Financial News
  • Investment News
  • Other News
    • Bursa News
    • Government News
    • Listing Companies News
    • Oversea Financial & Investment News
  • Interviews
    • Features Interviews
    • Corporate Interviews
  • Financial & Investment Articles
  • PR Newswire
  • Login
No Result
View All Result
Money Compass
Home PR Newswire

LOTTE Holdings establishes a new Healthcare and Biopharmaceutical Corporate Venture Capital

by
August 29, 2024
in PR Newswire
0
LOTTE Holdings establishes a new Healthcare and Biopharmaceutical Corporate Venture Capital
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

TOKYO, Aug. 29, 2024 /PRNewswire/ — LOTTE Holdings Co., Ltd. (“LOTTE Holdings”) is pleased to announce the establishment of a new Healthcare and Biopharmaceutical Corporate Venture Capital (“CVC”) dedicated to investing in biopharmaceuticals and next-generation modalities.

LOTTE Group operates under the group philosophy of “enriching people’s lives by providing superior products and services that our customers love and trust.”  Expanding its business across various fields, LOTTE Group entered the healthcare and biopharmaceutical sector in 2022 by establishing LOTTE BIOLOGICS, a Contract Development and Manufacturing Organization (CDMO).

Related posts

MindHYVE.ai™ Brings Agentic Intelligence and AGI Innovation to Africa’s Premier Tech Summit

MindHYVE.ai™ Brings Agentic Intelligence and AGI Innovation to Africa’s Premier Tech Summit

May 23, 2025
MindHYVE.ai™ Brings Agentic Intelligence and AGI Innovation to Africa’s Premier Tech Summit

MindHYVE.ai™ Brings Agentic Intelligence and AGI Innovation to Africa’s Premier Tech Summit

May 23, 2025

To further strengthen its commitment to healthcare and biopharmaceuticals, LOTTE Holdings has newly established a CVC dedicated to these fields. This CVC aims to gather cutting-edge insights to accelerate access to innovative technologies and promote investment in promising startups. In this first phase of investment, the CVC aims to target companies of all stages globally.

LOTTE Holdings CEO Genichi Tamatsuka expressed, “LOTTE Holdings has recently embarked on an ambitious venture into the healthcare sector, and we are committed to becoming a leading player in the health and wellness industry. This CVC marks our pivotal first step in establishing a platform to ignite innovation and drive our future growth.”

LOTTE Holdings Co., Ltd.

HQ: 20-1, Nishi-shinjuku 3-chome, Shinjuku-ku, Tokyo, Japan 160-0023

Representative Director & CEO: Genichi Tamatsuka

URL: https://lotte-hd.com/

Since its founding in 1948, LOTTE has continually advanced innovation. Today, LOTTE has headquarters in both Japan and Korea and operate businesses in approximately 30 countries worldwide, spanning a wide range of industries including food, distribution, retail, biopharma, data centers, hotels, entertainment, and construction.

LOTTE BIOLOGICS

HQ: 300 Olympic-ro, Songpa-gu Seoul, Seoul, 05551 Republic Of Korea

CEO: Richard Wonjik Lee

URL: https://www.lottebiologics.com/en/

LOTTE BIOLOGICS, established in 2022 and headquartered in Seoul, South Korea, is solidifying its competitiveness in the CDMO market. The company operates a manufacturing facility for biopharmaceutical antibody production in Syracuse, New York and is planning to establish a one-stop ADC service platform.

By the end of 2030, LOTTE BIOLOGICS expects to complete the construction and operate a 360kL bio campus in the Songdo area of Incheon, South Korea.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/lotte-holdings-establishes-a-new-healthcare-and-biopharmaceutical-corporate-venture-capital-302232766.html

SOURCE LOTTE Holdings

​ 

Previous Post

Asian Captive Conference 2024: Shaping the Future of Self-Insurance

Next Post

Melbourne Capital Group Broadens Malaysian Wealth Management Offering with Strategic Acquisition of Licensed Local Company

Next Post
Melbourne Capital Group Broadens Malaysian Wealth Management Offering with Strategic Acquisition of Licensed Local Company

Melbourne Capital Group Broadens Malaysian Wealth Management Offering with Strategic Acquisition of Licensed Local Company

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

BROWSE BY CATEGORIES

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire

BROWSE BY TOPICS

2018 League Balinese Culture Bali United Budget Travel business Champions League Chopper Bike Doctor Terawan industrial Istana Negara Malaysia Market Stories National Exam net zero emissions targets 2025 Renewable energy Visit Bali

Recent News

  • MindHYVE.ai™ Brings Agentic Intelligence and AGI Innovation to Africa’s Premier Tech Summit
  • MindHYVE.ai™ Brings Agentic Intelligence and AGI Innovation to Africa’s Premier Tech Summit
  • Robots and Human-Centric AI Dazzle at Opening of BEYOND Expo 2025

Category

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire
  • About
  • Advertise
  • Careers
  • Contact

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Features Interviews
  • Government News
  • Financial News
  • Investment News
  • Listing Companies News
  • Corporate Interviews
  • Bursa News
  • Financial & Investment Articles
  • Oversea Financial & Investment News

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved